Elevated serum potassium is a common clinical problem in patients with chronic kidney disease and end-stage renal disease. Hyperkalemia may be caused by either impaired renal excretion of potassium or by a shift of potassium into the extracellular space. In these programs leading experts discuss the role that the renin-angiotensin-aldosterone system (RAAS) system plays in the regulation of serum potassium levels, as well as, strategies for the management of hyperkalemia.
Upon completion of the educational activity, participants should be able to:
Discuss the incidence, prevalence, and pathophysiology of hyperkalemia in patients with chronic kidney disease and end-stage renal disease
Review the role of the renin-angiotensin-aldosterone system (RAAS) system and the impact on potassium homeostasis in patients with chronic kidney disease and end-stage renal disease
Identify the current and emerging management strategies for hyperkalemia in patients with chronic kidney disease and end-stage renal disease
This activity is intended for cardiologists, cardiothoracic surgeons, general internists, nurses, nurse practitioners, pharmacists and other healthcare professionals interested in improving clinical outcomes in patients with hyperkalemia.
There is no schedule for this activity.
There is no fee to register for this activity.
AKH Inc., Advancing Knowledge in Healthcare is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. AKH Inc., Advancing Knowledge in Healthcare designates this enduring activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME.
AKH, Inc., Advancing Knowledge in Healthcare is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.AKH, Inc., Advancing Knowledge in Healthcare approves this knowledge- based activity for 1.25 contact hour(s) (0.125 CEUs). UAN 0077-0000-16-047-H04-P. Initial Release Date: May 13, 2016.
AKH, Inc., Advancing Knowledge in Healthcare is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.This activity is awarded 1.25 Contact Hours.
AKH, Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider Number: 030803. This program is accredited for 1.25 contact hour(s) which includes 0 hour(s) of pharmacology. Program ID #21644-3. This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standard
AKH Inc. is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dieticians (RDs) and dietetic technicians, registered (DTRs) will receive 1.5 continuing professional education unit (CPEU) for completion of this program/material. CDR Accredited Provider #AN008. The focus of this activity is rated Level 2. Learners may submit evaluations of program/materials quality to the CDR at www.cdrnet.org